KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-3.41
↑ 17% vs avg
Percentile
P58
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-4.12
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -3.41 | -16.6% |
| 2024 | -2.93 | -38.5% |
| 2023 | -2.11 | +41.0% |
| 2022 | -3.58 | +52.5% |
| 2021 | -7.53 | -67.9% |
| 2020 | -4.48 | +58.1% |
| 2019 | -10.70 | -308.4% |
| 2018 | -2.62 | -48.0% |
| 2017 | -1.77 | +15.5% |
| 2016 | -2.09 | - |